About SAMNOVA PHARMACEUTICALS
SAMNOVA PHARMACEUTICALS is a Healthcare company based in India. Pharmaceutical manufacturing of generic drugs and nutraceuticals in India. The company has 1 employees. Its Indian entity Samnova Pharmaceuticals Private Limited reported revenue of ₹6.74 Cr. SAMNOVA PHARMACEUTICALS offers products and services including Generic Medicines and Nutraceuticals. Its focus areas include Pharmaceuticals, Generic Drug Manufacturing, Medicine Production and Nutraceuticals.
Company details
SAMNOVA PHARMACEUTICALS is recognized as a value-driven entity in the pharmaceutical industry across India. Quality medicines are provided at affordable prices, aligning with the objective of caring for peoples lives. Over 200 generic products are offered in areas like anti-infectives, analgesics, cardio-diabetic treatments, and nutraceuticals. Certifications including cGMP and WHO-GMP are held, guaranteeing high standards. Operations are conducted on a pan-India basis, serving healthcare professionals effectively.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website samnova.in
- Legal Name Samnova Pharmaceuticals Pvt. Ltd
- Date of Incorporation 21 Jul, 2021
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹6.74 Cr
FY 2025 · +55% YoY
- Net Profit₹5.1 Lakh
FY 2025 · 1% margin
- EBITDA₹10.5 Lakh
FY 2025 · 2% margin
- Employee Count1
Associated legal entities of SAMNOVA PHARMACEUTICALS
SAMNOVA PHARMACEUTICALS operates through Samnova Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Samnova Pharmaceuticals Private Limited CIN U33100GJ2021PTC124274 | Active | 21 Jul 2021 | Ahmedabad, Gujarat | ₹6.7 Cr | 6 | View details |
Products & Services of SAMNOVA PHARMACEUTICALS
SAMNOVA PHARMACEUTICALS offers a comprehensive portfolio of products and services, including Generic Medicines and Nutraceuticals.
Generic drugs are manufactured and supplied across therapeutic areas such as anti-infectives and analgesics to serve healthcare needs.
Nutraceutical products are provided to support wellness in areas like dietary and external preparations.
Board of directors of Samnova Pharmaceuticals Private Limited (SAMNOVA PHARMACEUTICALS)
Samnova Pharmaceuticals Private Limited is the primary company behind SAMNOVA PHARMACEUTICALS. The board of Samnova Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Monil Hirenkumar Doshi, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Monil Hirenkumar Doshi DIN 08172278 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
| Vijaykumar Ramchhabila Singh DIN 02787199 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
| Ashish Shashikant Katariya DIN 09248700 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
| Himanshu Vijaykumar Doshi DIN 00381380 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
| Sanjaykumar Ramchhabila Singh DIN 02740177 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
| Shashikant Zumbarlal Katariya DIN 02956956 | Director | 21 Jul 2021 | 5 yrs 3 mo | Samnova Pharmaceuticals Private Limited |
Financials of SAMNOVA PHARMACEUTICALS
Figures of Samnova Pharmaceuticals Private Limited, the primary company behind SAMNOVA PHARMACEUTICALS, for FY 2025. Revenue was ₹6.74 Cr (+55% year on year). Net profit was ₹5.1 Lakh (1% margin). EBITDA was ₹10.5 Lakh (2% margin). Revenue has grown at a compounded annual rate of +27% over three years.
- ₹6.74 CrRevenue · FY 2025 · +55% YoY
- ₹5.1 LakhNet profit · 1% margin
- ₹10.5 LakhEBITDA · 2% margin
- ₹3 LakhPaid-up capital
- +27%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Samnova Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for SAMNOVA PHARMACEUTICALS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SAMNOVA PHARMACEUTICALS
SAMNOVA PHARMACEUTICALS is headquartered in India.
SAMNOVA PHARMACEUTICALS has 1 employees.
The primary company behind SAMNOVA PHARMACEUTICALS, Samnova Pharmaceuticals Private Limited, reported revenue of ₹6.74 Cr for FY 2025, up 55% year on year.
SAMNOVA PHARMACEUTICALS is recognized as a value-driven entity in the pharmaceutical industry across India. Quality medicines are provided at affordable prices, aligning with the objective of caring for peoples lives. Over 200 generic products are offered in areas like anti-infectives, analgesics, cardio-diabetic treatments, and nutraceuticals. Certifications including cGMP and WHO-GMP are held, guaranteeing high standards. Operations are conducted on a pan-India basis, serving healthcare professionals effectively.
SAMNOVA PHARMACEUTICALS offers Generic Medicines and Nutraceuticals.
SAMNOVA PHARMACEUTICALS operates through Samnova Pharmaceuticals Private Limited.
The legal entities of SAMNOVA PHARMACEUTICALS currently have 6 directors, including Monil Hirenkumar Doshi, Vijaykumar Ramchhabila Singh, Ashish Shashikant Katariya and others.